Bridgefront Capital’s Curis CRIS Stock Holding History

Bridgefront Capital’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-55	Closed	-$178K	–	403
2021 Q2	$178K	Buy	+55	New	+$249K	0.07%	518

Other funds holding CRIS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Bridgefront Capital's CRIS Position: Q3 2021 in Review

Bridgefront Capital sold out of Curis (CRIS) in Q3 2021, closing a stake of 55 shares — an estimated $178K sold.

Bridgefront Capital first reported a position in CRIS in Q2 2021 and held it in 1 quarter. The position peaked at $178K in Q2 2021. 123 funds tracked by Wall St. Rank hold CRIS as of Q3 2021.

Bridgefront Capital reported no remaining Curis position as of Q3 2021 after selling out during the quarter.
Bridgefront Capital sold 55 Curis shares in Q3 2021, an estimated $178K.
Bridgefront Capital first reported a position in Curis in Q2 2021 and held it in 1 quarter.
Bridgefront Capital's Curis position peaked at $178K in Q2 2021.
123 funds tracked by Wall St. Rank held Curis as of Q3 2021.

Based on Bridgefront Capital's 13F filing for Q3 2021, filed 12 Nov 2021.